nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—Oxymetazoline—HTR2A—narcolepsy	0.0275	1	CrCbGaD
Xylometazoline—ADRA1D—forebrain—narcolepsy	0.00741	0.0982	CbGeAlD
Xylometazoline—HTR1B—brainstem—narcolepsy	0.00593	0.0786	CbGeAlD
Xylometazoline—HTR1D—brainstem—narcolepsy	0.00574	0.0761	CbGeAlD
Xylometazoline—HTR1B—forebrain—narcolepsy	0.00572	0.0759	CbGeAlD
Xylometazoline—HTR1D—forebrain—narcolepsy	0.00554	0.0734	CbGeAlD
Xylometazoline—ADRA1A—brainstem—narcolepsy	0.00441	0.0585	CbGeAlD
Xylometazoline—ADRA1A—forebrain—narcolepsy	0.00425	0.0564	CbGeAlD
Xylometazoline—HTR1B—midbrain—narcolepsy	0.00378	0.0501	CbGeAlD
Xylometazoline—HTR1D—midbrain—narcolepsy	0.00366	0.0485	CbGeAlD
Xylometazoline—ADRA2A—forebrain—narcolepsy	0.00323	0.0429	CbGeAlD
Xylometazoline—ADRA1B—brain—narcolepsy	0.00314	0.0417	CbGeAlD
Xylometazoline—ADRA1D—brain—narcolepsy	0.00307	0.0408	CbGeAlD
Xylometazoline—ADRA2C—medulla oblongata—narcolepsy	0.00293	0.0388	CbGeAlD
Xylometazoline—ADRA2C—midbrain—narcolepsy	0.00268	0.0355	CbGeAlD
Xylometazoline—HTR1B—brain—narcolepsy	0.00237	0.0315	CbGeAlD
Xylometazoline—ADRA2A—medulla oblongata—narcolepsy	0.00234	0.031	CbGeAlD
Xylometazoline—HTR1D—brain—narcolepsy	0.0023	0.0305	CbGeAlD
Xylometazoline—ADRA2A—midbrain—narcolepsy	0.00214	0.0283	CbGeAlD
Xylometazoline—ADRA1A—brain—narcolepsy	0.00177	0.0234	CbGeAlD
Xylometazoline—ADRA2C—brain—narcolepsy	0.00168	0.0223	CbGeAlD
Xylometazoline—ADRA2A—brain—narcolepsy	0.00134	0.0178	CbGeAlD
Xylometazoline—ADRA2B—Signaling by GPCR—P2RY11—narcolepsy	0.00109	0.00121	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.00107	0.00119	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00106	0.00119	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00106	0.00119	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00105	0.00117	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00105	0.00117	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.00104	0.00116	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00104	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00103	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00103	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00102	0.00113	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.00102	0.00113	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00101	0.00112	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.001	0.00111	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.000998	0.00111	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000993	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—NPS—narcolepsy	0.000992	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—TAC1—narcolepsy	0.000992	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000988	0.0011	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000988	0.0011	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000978	0.00109	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.000978	0.00109	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000978	0.00109	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000973	0.00108	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.000966	0.00108	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.000951	0.00106	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000941	0.00105	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000941	0.00105	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.000936	0.00104	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.000927	0.00103	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.000927	0.00103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HCRT—narcolepsy	0.000924	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000919	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000919	0.00102	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000915	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.000913	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.000912	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.000912	0.00102	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000908	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.000908	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PENK—narcolepsy	0.000907	0.00101	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.000907	0.00101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.000888	0.00099	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.000888	0.00099	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.000876	0.000976	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000868	0.000967	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000864	0.000963	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.000864	0.000963	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.000861	0.000959	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.000861	0.000959	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.000857	0.000956	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.000855	0.000953	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000854	0.000952	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000854	0.000952	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000854	0.000952	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00085	0.000947	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.000848	0.000945	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CHKB—narcolepsy	0.000844	0.000941	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.000843	0.000939	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.000843	0.000939	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000841	0.000937	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.000834	0.00093	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000831	0.000927	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.000831	0.000927	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.000825	0.000919	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PENK—narcolepsy	0.000824	0.000918	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.000814	0.000907	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00081	0.000903	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00081	0.000903	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.000795	0.000886	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000784	0.000873	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.000779	0.000868	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.000776	0.000865	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000772	0.000861	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.000772	0.000861	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—TRH—narcolepsy	0.000772	0.00086	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.00077	0.000858	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.000758	0.000844	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.000756	0.000843	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000755	0.000841	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000753	0.000839	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000753	0.000839	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.000749	0.000835	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000747	0.000833	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.000741	0.000826	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.000737	0.000821	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.000737	0.000821	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000732	0.000816	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.000725	0.000809	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.000725	0.000809	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.000721	0.000803	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00072	0.000803	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.000711	0.000793	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.00071	0.000792	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.00071	0.000792	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.000709	0.000791	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.000707	0.000788	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000701	0.000782	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—TRH—narcolepsy	0.000701	0.000781	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000694	0.000774	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.000692	0.000771	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000688	0.000767	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CHKB—narcolepsy	0.000685	0.000764	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00068	0.000758	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HRH3—narcolepsy	0.000677	0.000754	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.000673	0.00075	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HCRTR1—narcolepsy	0.000665	0.000741	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HCRTR2—narcolepsy	0.000665	0.000741	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.000661	0.000737	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.000659	0.000734	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.000659	0.000734	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.000654	0.000729	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—TAC1—narcolepsy	0.000645	0.000719	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—NPS—narcolepsy	0.000645	0.000719	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.000644	0.000718	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—P2RY11—narcolepsy	0.000642	0.000716	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00064	0.000713	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.000632	0.000704	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00063	0.000702	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PENK—narcolepsy	0.00063	0.000702	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.000625	0.000697	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.000622	0.000693	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.000621	0.000692	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.000621	0.000692	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.000621	0.000692	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.000621	0.000692	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PENK—narcolepsy	0.000617	0.000688	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRH3—narcolepsy	0.000614	0.000685	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.000611	0.000681	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.000611	0.000681	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.000605	0.000674	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.0006	0.000669	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—HTR2A—narcolepsy	0.000597	0.000665	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000595	0.000663	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00059	0.000658	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000585	0.000652	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.000574	0.00064	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CPT1B—narcolepsy	0.000574	0.000639	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000572	0.000638	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.000565	0.00063	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.000564	0.000628	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.000564	0.000628	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—NPS—narcolepsy	0.000561	0.000625	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—TAC1—narcolepsy	0.000561	0.000625	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.000557	0.000621	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.000552	0.000616	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.000549	0.000611	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HCRT—narcolepsy	0.000546	0.000609	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000543	0.000605	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000543	0.000605	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.000539	0.000601	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TRH—narcolepsy	0.000536	0.000597	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000532	0.000593	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.000524	0.000585	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TRH—narcolepsy	0.000524	0.000585	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	0.000524	0.000584	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	0.000524	0.000584	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.000515	0.000574	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.000515	0.000574	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000513	0.000572	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HCRT—narcolepsy	0.00051	0.000569	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—NPS—narcolepsy	0.000509	0.000567	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—TAC1—narcolepsy	0.000509	0.000567	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000505	0.000562	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000505	0.000562	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.000502	0.00056	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000502	0.000559	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000487	0.000543	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.000487	0.000543	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PENK—narcolepsy	0.000487	0.000543	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	0.000476	0.00053	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—NPS—narcolepsy	0.000476	0.00053	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRH3—narcolepsy	0.00047	0.000524	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.000468	0.000522	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.000468	0.000522	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000466	0.00052	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CPT1B—narcolepsy	0.000466	0.000519	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRH3—narcolepsy	0.00046	0.000513	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000458	0.000511	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000458	0.00051	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000458	0.00051	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PENK—narcolepsy	0.000455	0.000507	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000453	0.000505	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000447	0.000499	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000446	0.000497	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000436	0.000486	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000427	0.000476	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000425	0.000474	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000425	0.000474	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000416	0.000463	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000416	0.000463	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000414	0.000462	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TRH—narcolepsy	0.000414	0.000461	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000402	0.000448	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000397	0.000443	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	0.000396	0.000442	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TAC1—narcolepsy	0.000389	0.000434	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NPS—narcolepsy	0.000389	0.000434	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	0.000388	0.000433	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TRH—narcolepsy	0.000387	0.000431	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000386	0.000431	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000386	0.000431	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NPS—narcolepsy	0.000381	0.000425	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TAC1—narcolepsy	0.000381	0.000425	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.00038	0.000424	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000374	0.000416	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000369	0.000412	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRH3—narcolepsy	0.000363	0.000405	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000339	0.000378	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRH3—narcolepsy	0.000339	0.000378	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000338	0.000377	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000337	0.000376	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.000334	0.000372	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000333	0.000371	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000333	0.000371	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000315	0.000351	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000314	0.00035	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.00031	0.000346	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—narcolepsy	0.000306	0.000341	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TAC1—narcolepsy	0.000301	0.000335	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NPS—narcolepsy	0.000301	0.000335	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000296	0.00033	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	0.000286	0.000319	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000282	0.000314	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NPS—narcolepsy	0.000281	0.000313	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TAC1—narcolepsy	0.000281	0.000313	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000276	0.000308	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000276	0.000308	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000275	0.000307	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000275	0.000307	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000256	0.000285	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.00025	0.000279	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000246	0.000274	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000246	0.000274	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—narcolepsy	0.000234	0.000261	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000232	0.000259	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—narcolepsy	0.000229	0.000256	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000228	0.000254	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000228	0.000254	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.0002	0.000223	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—narcolepsy	0.000181	0.000202	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	0.000169	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000166	0.000185	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000148	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000137	0.000153	CbGpPWpGaD
